Reuters feature story: "Harvard Makes Ambituous Life Sciences Gamble"

<p><a href="http://today.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?view=CN&storyID=2006-06-02T120000Z_01_N31211645_RTRIDST_0_HEALTH-HARVARD-GENERAL-FEATURE.XML&rpc=66%5B/url%5D"&gt;http://today.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?view=CN&storyID=2006-06-02T120000Z_01_N31211645_RTRIDST_0_HEALTH-HARVARD-GENERAL-FEATURE.XML&rpc=66&lt;/a&gt;&lt;/p>

<p>Haha, I don't think Harvard has to work very hard to "make itself" one of the top life sciences schools in the world. :)</p>

<p>I wouldn't call this a gamble, it's more a demonstration that the world's top university has the forward-thinking and the committment necessary to stay there.</p>

<p>Bravo to Harvard and to Larry Summers for pushing forward in fields that should be explored. I certainly hope the momentum endures.</p>

<p>Best,
DMW</p>

<p>Yea, and there are several new concentrations added, right?</p>

<p>Now, the question is, how will Biomedical engineering cirriculum be affected?</p>

<p>Hey, I have a question, for any current undergrads who might know -- </p>

<p>Are the TFs for biology classes all from the GSAS-only programs (MCB particularly) or are some of them from the medical school (BBS, etc)? Our teaching requirement seems to be normally fulfilled by TAing medical school classes, but I'd much rather TA for undergrads than medical students.</p>